(ii) The solicitation number is FDA-SOL-17-1180187 and is being issued as a Request for Proposal (RFP).
(iii) This solicitation and incorporated provisions are those in effect through Federal Acquisition Circular 2005-95.
(iv) This solicitation is in accordance with FAR 19.805, Competitive 8a procedures and is limited to eligible 8a companies. The Small Business Administration acceptance number is 0353/17/878. 8a Companies with the capability to meet our requirement as defined in the solicitation attachments are encouraged to respond. The NAICS code is 541512, Computer Systems Design Services. The small business size standard is $27.5M. The Government intends to issue an Indefinite Delivery Indefinite Quantity (IDIQ) Contract with a five year ordering period. In addition to the IDIQ contract, FDA intends to simultaneously issue and award three task orders under this IDIQ.
At the discretion of the Contracting Officer, the government may use Labor Hour, Time and Materials, Firm Fixed Price contract types, or a combination thereof, for the task orders. Each Request for Task Order Proposal (RFTOP) issued under this contract will identify the Government's determination of contract type.
(v) & (vi) The FDA requires the purchase and implementation of a Pharmacovigilance Commercial Off the Shelf (COTS) product to replace FDA's Adverse Event Reporting System (FAERS), continued Operations and Maintenance (O&M) of Legacy FAERs, and Development, Modernization and Enhancments (DME) / O&M of FDA's Global Substance Registration System (GSRS) (please see the solicitation attachments for more detail on FDA's requirements).
(vii) PERIOD OF PERFORMANCE: (est) 09/14/2017 - 09/13/2022
(viii) The provision at FAR 52.212-1 titled, "Instructions to Offerors -Commercial" (JAN 2017), applies to this acquisition and is available at website: http://farsite.hill.af.mil/reghtml/regs/far2afmcfars/fardfars/far/12.htm#P257_45709.
(ix) The provision at FAR 52.212-2, titled, "Evaluation of Commercial Items" (OCT 2014), is applicable to this acquisition.
This evaluation will be conducted using a combination of Go / No criteria and best value methodology. The Government reserves the right to establish a competitive range and award without discussions. Technical merit will more important than price in evaluating proposals (Please see RFP Attachment No. 1: IDIQ Terms and Conditions for Instructions to Offerors and Evaluation Criteria)
(xiv & xv) N/A
(xvi & xvii) All questions must be submitted in writing to Jody.O'[email protected] no later than Wednesday, August 2, 2017 at 1pm ET. Please note the FDA solicitation number (FDA-SOL-17-1180187) and project title (FAERS II) must be identified in the subject line of all correspondence and submittal of questions. Answers to all questions will be posted as an amendment to the solicitation on Federal Business Opportunities. Technical and Business Proposals are due no later than Friday, August 18, 2017 at 12pm ET. See attached IDIQ Terms and Conditions, Section 4.1 for general instructions on proposal submissions.